Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease · Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Weill Cornell Medicine Brain Health Imaging Institute, New York, New York, United States
Contact: Study coordinator (Edward Spector, BS) · ejs4002@med.cornell.edu · 6469628506

Study leads

Tracy A Butler, MD
Principal Investigator
Weill Medical College of Cornell University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

MCI · MCI-AD, Early Stage Alzheimer's Disease · Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Lodz, Poland

NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

Alzheimer s Disease · Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease · Mild Dementia

Abroad (travel likely)Recruiting

Houston, United States

Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Abroad (travel likely)Recruiting

Toronto, Canada

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Alzheimer's Disease

Abroad (travel likely)Recruiting

Los Angeles, United States